Antibiotics for preventing complications in children with measles

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Kabra, Sushil K ^a   Lodha, Rakesh ^a   Hilton, Deborah J ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Basic Statistical Consultancy   (Australia)

Author keywords

Anti bacterial agents *therapeutic use ; Child; Human; Measles * complications; *drug therapy ; Pneumonia drug therapy; *prevention control ; Randomized controlled trials as topic

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CHLORTETRACYCLINE; COTRIMOXAZOLE; DIPHTHERIA ANTIBODY; PENICILLIN G; PLACEBO; PROCAINE PENICILLIN; PROSEPTASINE; RETINOL; SULFANILAMIDE; SULFATHIAZOLE; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ATTRIBUTABLE RISK; BRONCHOPNEUMONIA; CERVICAL ADENITIS; CLINICAL TRIAL; CONJUNCTIVITIS; CROUP; DATA BASE; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; EMBASE; FEVER; GASTROENTERITIS; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFORMATION PROCESSING; INFORMATION RETRIEVAL; LUNG COLLAPSE; MEASLES; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SUPPURATIVE OTITIS MEDIA; SYSTEMATIC REVIEW; TONSILLITIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 55049120569     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001477.pub3     Document Type: Review

References (37)

1. Anderson 1939 {published data only} Anderson T. Sulphanilamide in the treatment of measles. British Medical Journal 1939;i:716-8.
2. Garly 2006 {published data only} Garly M, Balé C, Martins LC, Whittle HC, Nielsen J, Lisse IM, et al.Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. British Medical Journal 2006;333(7581):1245.
3. Gibel 1942 {published data only} Gibel H, Litvak AM. Sulfathiazole in the treatment of measles and its complications. Journal of Pediatrics 1942;21:315-20.
4. Hogarth 1939 {published data only} Hogarth JC. Para-benzylaminobenzenesulphonamide in the prevention of measles complications. British Medical Journal 1939;i:718-20.
5. Karelitz 1951 {published data only} Karelitz S, King H, Curtis B, Wechsel M. Use of Aureomycin and penicillin in the treatment of rubeola in the pre-eruptive and early eruptive phase. Pediatrics 1951;7:193-9.
6. Karelitz 1954 {published data only} Karelitz S, Chang C, Matthews ZE. The prophylaxis and treatment of bacterial complications of measles with benzethacil and aqueous procaine penicillin G. Journal of Pediatrics 1954;44:357-63.
7. Prasad 1967 {published data only} Prasad R, Mathur GP, Trehan OP, Mehrotra ML, Dayal RS. A clinical and radiological study of measles. Indian Pediatrics 1967;4:243-50.
8. Samb 1995 {published data only} Samb B, Simondon F, Aaby P, Whittle H, Seck AM. Prophylactic use of antibiotics and reduced case fatality in measles infection. Pediatric Infectious Disease Journal 1995;14:695-6.
9. Thompson 1938 {published data only} Thompson AR, Greenfield CRM. Chemotherapy in measles and whooping-cough: prophylaxis and treatment of complications. Lancet 1938;2:991-4.
10. Weinstein 1955 {published data only} Weinstein L. Failure of chemotherapy to prevent the bacterial complications of measles. New England Journal of Medicine 1955;253:679-82.
11. Aaby 1984 Aaby P, Bukh J, Lisse IM, Smits AJ. Overcrowding and intensive exposure as determinants of measles mortality. American Journal of Epidemiology 1984;120:49-63. [MEDLINE: 1984253708]
12. Aaby 1990 Aaby P, Bukh J, Kronborg D, Lisse IM, da Silva MC. Delayed excess mortality after exposure to measles during the first six months of life. American Journal of Epidemiology 1990;132:211-9.
13. Anonymous 2002 Anonymous. Global measles mortality reduction and regional elimination, 2000-2001: part I. Weekly Epidemiologic Records 2002;77:50-5.
14. Anonymous 2006 Anonymous. Progress in reducing global measles deaths: 1999-2004. Weekly Epidemiologic Records 2006;10:90-94.
15. Bhaskaram 1984 Bhaskaram P, Reddy V, Raj S, Bhatnagar RC. Effect of measles on the nutritional status of preschool children. Journal of Tropical Medicine and Hygiene 1984;87:21-5.
16. Burström 1999 Burström B, Diderichsen F, Smedman L. Child mortality in Stockholm during 1885-1910: the impact of household size and number of children in the family on the risk of death from measles. American Journal of Epidemiology 1999;149:1134-41.
17. Caulfield 2004 Caulfield LE, de Onis M, Blössner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. American Journal of Clinical Nutrition 2004;80:193-8.
18. Deivanayagam 1994 Deivanayagam N, Mala N, Ahamed SS, Shankar VJ. Measles associated diarrhea and pneumonia in south India. Indian Pediatrics 1994;31:35-40.
19. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. British Medical Journal 1994;309:1286-91.
20. Dover 1975 Dover AS, Escobar JA, Duenas AL, Leal EC. Pneumonia associated with measles. Journal of the American Medical Association 1975;234(6):612-4.
21. Ellison 1931 Ellison JB. Pneumonia in measles. Archives of Disease in Childhood 1931;6:37-51.
22. Gadomski 1993 Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatric Infectious Disease Journal 1993;12:115-20.
23. Gremillion 1981 Gremillion DH, Crawford GE. Measles pneumonia in young adults. An analysis of 106 cases. American Journal of Medicine 1981;71(4):539-42.
24. Huiming 2005 Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database of Systematic Reviews 2005, Issue 4. [Art. No.: CD001479. DOI: 10.1002/14651858.CD001479.pub3]
25. Hull 1983 Hull HF, Williams PJ, Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet 1983;1:972-5.
26. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
27. Kaschula 1983 Kaschula RO, Druker J, Kipps A. Late morphologic consequences of measles: a lethal and debilitating lung disease among the poor. Reviews of Infectious Diseases 1983;5(3):395-404.
28. Koster 1981 Koster FT, Curlin GC, Aziz KM, Haque A. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bulletin of the World Health Organization 1981;59:901-8.
29. Morton 1986 Morton R, Mee J. Measles pneumonia: lung puncture findings in 56 cases related to chest X-ray changes and clinical features. Annals of Tropical Paediatrics 1986;6:41-5.
30. Olson 1975 Olson RW, Hodges GR. Measles pneumonia. Bacterial suprainfection as a complicating factor. Journal of the American Medical Association 1975;232(4):363-5.
31. Perry 2004 Perry RT, Halsey NA. The clinical significance of measles: a review. Journal of Infectious Diseases 2004;89(Suppl): 4-16.
32. Reddy 1986 Reddy V, Bhaskaram P, Raghuramulu N, Milton RC, Rao V, Madhusudan J, et al.Relation between measles, malnutrition and blindness; a prospective study in Indian children. American Journal of Clinical Nutrition 1986;44:925-30.
33. Wesley 1971 Wesley AG, Sutton JB, Widrich AJ. The aetiology of pneumonia associated with measles in Bantu children. South African Medical Journal 1971;45(48):1402-4.
34. WHO 1995 World Health Organization. Clinical research on treatment of measles: report of a meeting. Geneva, WHO 1995. (WHO/CDR/95.15.) 1995; Vol. 95.15.
35. Shann 1997 Shann F. Meta-analysis of trials of prophylactic antibiotics for children with measles: inadequate evidence. British Medical Journal 1997;314:334-6.
36. Shann 1999 Shann F, D'Souza RM, D'Souza R. Antibiotics for preventing pneumonia in children with measles. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD001477.pub2]
37. Shann 2000 Antibiotics for preventing pneumonia in children with measles. Shann F, D'Souza RM, D'Souza R. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD001477.pub2]